Cloud-based cardiac imaging company inHeart has received $4.2 million in funding for its product that creates a 3D replicate image of a patient’s heart to assist in pre-procedural planning.
European venture capital firm Elaia led this current round of funding, with proceeds going toward developing the product in Europe and gaining access to the U.S. market, according to a July 2 announcement.
Pessac, France-based inHeart is a spinoff company from IHU Liryc and Intria, both leading centers in cardiac electrophysiology and digital science and technology.
Technology produced by inHeart is used in 40 institutions around the globe, the company said Thursday. Its cloud software turns preoperative medical images into a 3D “digital twin” of the patient’s heart enabling providers to plan procedures and navigate instruments during surgery. The firm is currently looking to improve treatments for heart rhythm disorders such as arrhythmias, given that certain forms require a repeat procedure in 40% of patients.
“My patients directly benefit from this technology and their arrhythmias are less recurrent,” Co-founder of inHeart and cardiologist Pierre Jaïs said in the announcement. “[The] future will be even brighter with artificial intelligence that already allows us to very quickly process patient scans and that will enable…the prediction of patients at risk and the refinement of therapeutic strategies."